PMGC HOLDINGS INC. Professional Fees
PMGC HOLDINGS INC. (ELAB) reported Professional Fees of $552.56 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ProfessionalFees · last filed 2026-08-14
- PMGC HOLDINGS INC. professional fees for the quarter ending 2026-06-30 was $552.56K, a 94.44% increase year-over-year.
- PMGC HOLDINGS INC. professional fees for the quarter ending 2026-03-31 was $592.02K, a 122.17% increase year-over-year.
- PMGC HOLDINGS INC. professional fees for the quarter ending 2025-12-31 was $483.27K, a 62.82% increase year-over-year.
- PMGC HOLDINGS INC. professional fees for the quarter ending 2025-09-30 was $389.11K, a 123.07% increase year-over-year.
- PMGC HOLDINGS INC. professional fees for fiscal 2025 was $1.42M, a 152.65% increase from fiscal 2024.
- PMGC HOLDINGS INC. professional fees for fiscal 2024 was $563.24K, a 324.77% increase from fiscal 2023.
- PMGC HOLDINGS INC. professional fees for fiscal 2023 was $132.60K, a 31.08% decline from fiscal 2022.
- PMGC HOLDINGS INC. professional fees for fiscal 2022 was $192.41K.
| Period end | Professional Fees 3 month | Professional Fees 3 month as first filed | Professional Fees 6 month | Professional Fees 6 month as first filed | Professional Fees 9 month | Professional Fees 9 month as first filed | Professional Fees 12 month | Professional Fees 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $552.56K 10-Q · filed 2026-08-14 | $1.14M 10-Q · filed 2026-08-14 | $1.63M derived: sum of 3 quarters · filed 2026-08-14 | $2.02M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | $592.02K 10-Q · filed 2026-05-15 | $1.08M derived: sum of 2 quarters · filed 2026-05-15 | $1.46M derived: sum of 3 quarters · filed 2026-05-15 | $1.75M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | $483.27K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $872.38K derived: sum of 2 quarters · filed 2026-03-30 | $1.16M derived: sum of 3 quarters · filed 2026-08-14 | $1.42M 10-K · filed 2026-03-30 | ||||
| 2025-09-30 | $389.11K 10-Q · filed 2025-11-14 | $673.29K derived: sum of 2 quarters · filed 2026-08-14 | $939.75K 10-Q · filed 2025-11-14 | $1.24M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | $284.18K 10-Q · filed 2026-08-14 | $550.64K 10-Q · filed 2026-08-14 | $847.45K derived: sum of 3 quarters · filed 2026-08-14 | $1.02M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-03-31 | $266.47K 10-Q · filed 2026-05-15 | $563.28K derived: sum of 2 quarters · filed 2026-05-15 | $737.71K derived: sum of 3 quarters · filed 2026-05-15 | $786.42K derived: sum of 4 quarters · filed 2026-05-15 | ||||
| 2024-12-31 | $296.81K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $471.25K derived: sum of 2 quarters · filed 2026-03-30 | $519.95K derived: sum of 3 quarters · filed 2026-03-30 | $563.24K 10-K · filed 2026-03-30 | ||||
| 2024-09-30 | $174.44K 10-Q · filed 2025-11-14 | $249.89K 10-Q · filed 2024-11-14 | $223.14K derived: sum of 2 quarters · filed 2025-11-14 | $266.43K 10-Q · filed 2025-11-14 | $587.95K 10-Q · filed 2024-11-14 | -$51.35K derived: sum of 4 quarters · filed 2025-11-14 | ||
| 2024-06-30 | $48.71K 10-Q · filed 2025-08-13 | $158.14K 10-Q · filed 2024-08-14 | $92.00K 10-Q · filed 2025-08-13 | $338.06K 10-Q · filed 2024-08-14 | -$225.79K derived: sum of 3 quarters · filed 2025-08-13 | -$82.13K derived: sum of 4 quarters · filed 2025-08-13 | ||
| 2024-03-31 | $43.29K 10-Q · filed 2025-05-14 | $179.92K 10-Q · filed 2024-05-15 | -$274.49K derived: sum of 2 quarters · filed 2025-05-14 | -$130.84K derived: sum of 3 quarters · filed 2025-05-14 | $38.09K derived: sum of 4 quarters · filed 2025-05-14 | |||
| 2023-12-31 | -$317.78K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | -$174.13K derived: sum of 2 quarters · filed 2025-03-28 | -$5.20K derived: sum of 3 quarters · filed 2025-03-28 | $132.60K 10-K · filed 2025-03-28 | $579.11K 10-K · filed 2024-03-29 | |||
| 2023-09-30 | $143.65K 10-Q · filed 2024-11-14 | $143.65M 10-Q · filed 2023-12-11 | $312.59K derived: sum of 2 quarters · filed 2024-11-14 | $450.38K 10-Q · filed 2024-11-14 | $450.38M 10-Q · filed 2023-12-11 | -$94.22M derived: sum of 4 quarters · filed 2024-11-14 | ||
| 2023-06-30 | $168.93K 10-Q · filed 2024-08-14 | $306.73K 10-Q · filed 2024-08-14 | -$94.37M derived: sum of 3 quarters · filed 2024-08-14 | -$44.66M derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | $137.80K 10-Q · filed 2024-05-15 | -$94.53M derived: sum of 2 quarters · filed 2024-05-15 | -$44.83M derived: sum of 3 quarters · filed 2024-05-15 | |||||
| 2022-12-31 | -$94.67M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | -$44.97M derived: sum of 2 quarters · filed 2024-03-29 | $192.41K 10-K · filed 2024-03-29 | |||||
| 2022-09-30 | $49.71M 10-Q · filed 2023-12-11 | $94.86M 10-Q · filed 2023-12-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B |